OncoGenex Announces Completion of Patient Enrollment in the Rainier™ Clinical Trial Evaluating Apatorsen in Combination with ABRAXANE® plus Gemcitabine in Patients with Metastatic Pancreatic Cancer

… to evaluate progression-free survival (PFS), tumor response rates, safety, tolerability and … in bladder, lung, pancreatic and prostate cancers. For more information on apatorsen … castrate-resistant prostate cancer and in patients with advanced, unresectable non-small cell lung cancer …